Insider · CIK 0001835544
Chidozie Ugwumba
owner
Files at CLNN (Clene Inc.). First filing Dec 18, 2025, latest May 13, 2026.
In brief
Chidozie Ugwumba files SEC Form 4 as 10% owner at CLNN (Clene Inc.). Since Dec 18, 2025, Chidozie Ugwumba has reported 0 open-market buys worth $0 and 22 open-market sells worth $5.8M, the latest filed on May 13, 2026.
A track record needs three past buys with six months of prices behind them; Chidozie Ugwumba has 0, so none is measured yet.
The newest scored trade: sold $604k of CLNN on May 11, 2026, filed May 13, 2026, scored 41 (moderate). In the last 12 months: 0 buys worth $0 and 22 sells worth $5.8M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 22
$0 bought, $5.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLNN: Clene Inc.
CLNNOct 9, 2026 · close 3.86
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | CLNNsell Clene Inc. | $604k 95,473 shares | -48% | +174% from low-48% from high | |
| 40Moderate | CLNNsell Clene Inc. | $530k 78,679 shares | -28% | +159% from low-51% from high | |
| 22Weak | CLNNsell Clene Inc. | $113k 19,497 shares | -7% | +147% from low-53% from high | |
| 33Weak | CLNNsell Clene Inc. | $403k 65,663 shares | -18% | +159% from low-51% from high | |
| 25Weak | CLNNsell Clene Inc. | $252k 39,162 shares | -10% | +168% from low-49% from high | |
| 22Weak | CLNNsell Clene Inc. | $120k 24,925 shares | -6% | +116% from low-59% from high | |
| 12Weak | CLNNsell Clene Inc. | $21k 4,278 shares | -1% | +106% from low-61% from high | |
| 35Weak | CLNNsell Clene Inc. | $494k 100,997 shares | -19% | +99% from low-62% from high | |
| 22Weak | CLNNsell Clene Inc. | $100k 17,909 shares | -3% | +142% from low-54% from high | |
| 12Weak | CLNNsell Clene Inc. | $23k 5,559 shares | -1% | +80% from low-66% from high | |
| 22Weak | CLNNsell Clene Inc. | $105k 24,770 shares | -4% | +76% from low-67% from high | |
| 22Weak | CLNNsell Clene Inc. | $96k 19,274 shares | -3% | +114% from low-59% from high | |
| 22Weak | CLNNsell Clene Inc. | $97k 18,221 shares | -3% | +129% from low-57% from high | |
| 23Weak | CLNNsell Clene Inc. | $162k 32,474 shares | -5% | +113% from low-60% from high | |
| 26Weak | CLNNsell Clene Inc. | $292k 58,289 shares | -8% | +115% from low-59% from high | |
| 25Weak | CLNNsell Clene Inc. | $256k 44,975 shares | -6% | +152% from low-52% from high | |
| 21Weak | CLNNsell Clene Inc. | $78k 12,918 shares | -2% | +143% from low-54% from high | |
| 22Weak | CLNNsell Clene Inc. | $99k 17,110 shares | -2% | +148% from low-53% from high | |
| 20Weak | CLNNsell Clene Inc. | $73k 12,234 shares | -2% | +149% from low-53% from high | |
| 20Weak | CLNNsell Clene Inc. | $73k 11,671 shares | -1% | +164% from low-50% from high | |
| 20Weak | CLNNsell Clene Inc. | $65k 9,949 shares | -3% | +182% from low-47% from high | |
| 47Moderate | CLNNsell Clene Inc. | $1.7M 257,795 shares | -40% | +205% from low-42% from high |
Transactions
The newest 50 of 66 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | CLNN Clene Inc. | JOther Warrant to Purchase Common Stock (Tranche B, $30.00 strike)derivativeindirect: By SymBiosis II LLC | -375,000 | - | - | 0 | Aug 6, 2026 |
| Jul 17, 2026 | CLNN Clene Inc. | JOther Common Stock Purchase Warrant ($4.82 strike)derivativeindirect: By SymBiosis II LLC | -424,358 | - | - | 0 | Aug 6, 2026 |
| May 11, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -22,177 | $6.75 | $150k | 176,713 | May 13, 2026 |
| May 12, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -73,296 | $6.20 | $454k | 103,417 | May 13, 2026 |
| May 1, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -5,795 | $6.01 | $35k | 271,774 | May 5, 2026 |
| May 4, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -72,884 | $6.80 | $496k | 198,890 | May 5, 2026 |
| Apr 28, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -1,591 | $5.90 | $9,387 | 295,475 | Apr 30, 2026 |
| Apr 29, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -12,170 | $5.63 | $69k | 283,305 | Apr 30, 2026 |
| Apr 30, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -5,736 | $6.08 | $35k | 277,569 | Apr 30, 2026 |
| Apr 20, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -4,318 | $6.12 | $26k | 358,411 | Apr 22, 2026 |
| Apr 21, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -61,345 | $6.14 | $377k | 297,066 | Apr 22, 2026 |
| Apr 15, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -6,374 | $6.48 | $41k | 395,517 | Apr 17, 2026 |
| Apr 16, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -7,748 | $6.40 | $50k | 387,769 | Apr 17, 2026 |
| Apr 17, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -25,040 | $6.43 | $161k | 362,729 | Apr 17, 2026 |
| Apr 2, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -24,925 | $4.81 | $120k | 401,891 | Apr 6, 2026 |
| Apr 1, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -4,278 | $4.97 | $21k | 426,816 | Apr 1, 2026 |
| Mar 27, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -17,470 | $4.75 | $83k | 514,621 | Mar 31, 2026 |
| Mar 30, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -15,536 | $5.10 | $79k | 499,085 | Mar 31, 2026 |
| Mar 31, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -67,991 | $4.88 | $332k | 431,094 | Mar 31, 2026 |
| Mar 24, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -5,492 | $5.78 | $32k | 544,508 | Mar 26, 2026 |
| Mar 25, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -7,098 | $5.50 | $39k | 537,410 | Mar 26, 2026 |
| Mar 26, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -5,319 | $5.40 | $29k | 532,091 | Mar 26, 2026 |
| Feb 3, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,559 | $4.10 | $23k | 550,000 | Feb 5, 2026 |
| Jan 29, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -15,284 | $4.32 | $66k | 565,045 | Feb 2, 2026 |
| Jan 30, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,686 | $4.13 | $23k | 559,359 | Feb 2, 2026 |
| Feb 2, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -3,800 | $4.04 | $15k | 555,559 | Feb 2, 2026 |
| Jan 26, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -6,418 | $5.02 | $32k | 593,185 | Jan 28, 2026 |
| Jan 27, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -4,139 | $5.08 | $21k | 589,046 | Jan 28, 2026 |
| Jan 28, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By SymBiosis II, LLC | -8,717 | $4.91 | $43k | 580,329 | Jan 28, 2026 |
| Jan 22, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -12,665 | $5.32 | $67k | 605,159 | Jan 23, 2026 |
| Jan 23, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,556 | $5.27 | $29k | 599,603 | Jan 23, 2026 |
| Jan 16, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -7,923 | $5.13 | $41k | 642,375 | Jan 21, 2026 |
| Jan 20, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -12,432 | $4.80 | $60k | 629,943 | Jan 21, 2026 |
| Jan 21, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -12,119 | $5.05 | $61k | 617,824 | Jan 21, 2026 |
| Jan 13, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -26,105 | $4.89 | $128k | 682,482 | Jan 16, 2026 |
| Jan 14, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -19,621 | $5.12 | $100k | 662,861 | Jan 16, 2026 |
| Jan 15, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -12,563 | $5.10 | $64k | 650,298 | Jan 16, 2026 |
| Jan 8, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -3,195 | $6.09 | $19k | 750,367 | Jan 12, 2026 |
| Jan 9, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -9,075 | $6.27 | $57k | 741,292 | Jan 12, 2026 |
| Jan 12, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -32,705 | $5.50 | $180k | 708,587 | Jan 12, 2026 |
| Jan 5, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,869 | $5.87 | $34k | 760,611 | Jan 7, 2026 |
| Jan 6, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -3,111 | $6.04 | $19k | 757,500 | Jan 7, 2026 |
| Jan 7, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -3,938 | $6.29 | $25k | 753,562 | Jan 7, 2026 |
| Dec 31, 2025 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -13,095 | $5.81 | $76k | 770,495 | Jan 2, 2026 |
| Jan 2, 2026 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -4,015 | $5.73 | $23k | 766,480 | Jan 2, 2026 |
| Dec 29, 2025 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -8,096 | $5.95 | $48k | 787,728 | Dec 31, 2025 |
| Dec 30, 2025 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -4,138 | $6.03 | $25k | 783,590 | Dec 31, 2025 |
| Dec 23, 2025 | CLNN Clene Inc. | EExpiration of short derivative Common Stockindirect: By Symbiosis II, LLC | +424,358 | $0.00 | $424 | 807,495 | Dec 30, 2025 |
| Dec 23, 2025 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -6,831 | $6.27 | $43k | 800,664 | Dec 30, 2025 |
| Dec 24, 2025 | CLNN Clene Inc. | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -1,490 | $6.27 | $9,342 | 799,174 | Dec 30, 2025 |
50 of 66 rows shown.
Questions about Chidozie Ugwumba
Answered from the filings on this page, as of the latest one.
Is Chidozie Ugwumba buying or selling?
In the last 12 months Chidozie Ugwumba reported 0 open-market buys worth $0 and 22 open-market sells worth $5.8M on SEC Form 4; the latest was sold $604k of CLNN on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Chidozie Ugwumba's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chidozie Ugwumba has 0.
Where does Chidozie Ugwumba file Form 4?
Chidozie Ugwumba has filed Form 4 at CLNN (Clene Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.